Can I read Diabetes Obesity Metabolism - 2026 - Gasoyan - Obesity Treatments and Weight Changes in Clinical Practice After on EtoBox?

Diabetes Obesity Metabolism - 2026 - Gasoyan - Obesity Treatments and Weight Changes in Clinical Practice After by alvaroalbano is a document available to read on EtoBox.

What is Diabetes Obesity Metabolism - 2026 - Gasoyan - Obesity Treatments and Weight Changes in Clinical Practice After about?

This study investigates the obesity treatments pursued by patients after discontinuing semaglutide or tirzepatide, analyzing data from 7938 adults over a period from 2021 to 2025. Findings indicate that 19.6% of patients restarted the original medication, while 35.2% sought alternative treatments, with an average weight change of -8.4% from baseline to discontinuation and a small change of 0.5% one year post-discontinuation. The study highlights significant individual variability in weight outcomes followin

Author

alvaroalbano

Language

EN